BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Tandem Labs' New England Facility Doubles Discovery Support Capacity - Increasing Foothold in New England


10/9/2007 8:44:18 AM

WOBURN, Mass., Oct. 9 /PRNewswire/ -- Tandem Labs, a leading contract research organization (CRO) providing bioanalytical, immunoanalytical, and pharmacokinetic (PK)/pharmacodynamic (PD) services to the pharmaceutical industry, announced that it has acquired additional MDS SCIEX API 5000(TM) and 4000(TM) LC/MS/MS systems for its New England facility in Woburn, Massachusetts. This acquisition doubles the facility's current triple quadrupole LC/MS/MS capacity, allowing it to better serve its clientele through this expansion in capacity.

"Tandem Labs acquired these additional instruments to further increase our capacity in the critical New England region," said Denis C.K. Lin, Ph.D., president and CEO. "These assets will significantly enhance our reach within the drug discovery and development industry, particularly in Massachusetts as well as other Northeast states."

The New England operation is focused upon providing rapid turnaround non- GLP discovery PK/PD services in addition to metabolite identification and biomarker services. Combined with other advanced mass spectrometric platforms beyond the triple quadrupoles, the New England facility also uses proprietary informatics to reduce the difficulty, complexity, and time-consuming nature of developing and launching a drug to market. DMDiscovery(TM) is a drug metabolism technology that increases the productivity of drug metabolite identification and quantification. MarkerScan(TM) is a biomarker discovery and screening process that efficiently identifies potential biomarkers that can be used to increase the understanding of disease, diagnosis, and predictive models as well as drug compound safety, efficacy, and side-effect profiles.

Tandem Labs has additional facilities in Utah and New Jersey; the Utah location focuses primarily on GLP bioanalytical services and discovery support while the New Jersey location specializes in GLP-compliant bioanalysis on LC/MS/MS and immunoanalytical platforms.

About Tandem Labs

Tandem Labs is a leading CRO specializing in advanced mass spectrometry, immunoanalytical support, and PK/PD for the pharmaceutical/biotechnology industries in the United States and internationally. With more than 30 LC/MS/MS instruments and 54,000-square-feet available, Tandem Labs exists to serve the needs of its clients. By applying scientific ingenuity, responsive communication, flexible client service, disciplined compliance, and a commitment to information technology, Tandem supports drug discovery and development by offering a comprehensive suite of customizable services that help clients reduce their overall time in bringing new medicines to market.

denis.lin@tandemlabs.comjean.pineault@tandemlabs.com

CONTACT: Denis Lin, Ph.D., President & CEO, +1-801-293-2400,
denis.lin@tandemlabs.com, or Jean Pineault, M.S., Vice President, Sales &
Marketing, +1-609-228-0201, jean.pineault@tandemlabs.com, both of Tandem
Labs

Web site: http://www.tandemlabs.com//



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES